Mar 13, 2019 / 03:15PM GMT
Jack Meehan - Barclays Bank PLC, Research Division - VP & Senior Research Analyst
We're going to do our audience response questions. As we'll kick that off, please use the BlackBerry-type devices. First question, what do you view as Illumina's organic growth profile over the next 3 years?
(Voting)
Jack Meehan - Barclays Bank PLC, Research Division - VP & Senior Research Analyst
I think this might be an easy one here. We do ask the same question for every company. We have some naysayers but 2/3 in the double digits. Next question. How confident is your outlook for growth in China, which has been an important growth for Illumina?
(Voting)
Jack Meehan - Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Kind of right down the middle split. And then finally, how would you like to see Sam deploying capital in 2019?
(Voting)
Jack Meehan - Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Interesting.
Illumina Inc at Barclays Global Healthcare Conference Transcript
Mar 13, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers